Michael Cola
Overview
Michael Cola received an average of $2M in total compensation, including $59K in salary, at Avalo Therapeutics from 2020 to 2022.
Source: SEC filings on October 19, 2023 and April 25, 2022.
Related executives
We found 16 more executives who work or worked at Avalo Therapeutics.
Garry Neil
Avalo Therapeutics
Chief Executive Officer
Stephen Smolinski
Avalo Therapeutics
Former Chief Commercial Officer
Christopher Sullivan
Avalo Therapeutics
Chief Financial Officer
Schond Greenway
Avalo Therapeutics
Chief Financial Officer
H Wilkins
Avalo Therapeutics
Chief Medical Officer
Simon Pedder
Avalo Therapeutics
Chairman
Pericles Calias
Avalo Therapeutics
Chief Scientific Officer
Joseph Miller
Avalo Therapeutics